The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions

被引：50

作者：

Khezri, Mohammad Rafi ^{[1
]}

Jafari, Reza ^{[2
]}

Yousefi, Keyvan ^{[3
]}

Zolbanin, Naime Majidi ^{[4
,5
,6
]}

机构：

[1] Urmia Univ Med Sci, Student Res Comm, Orumiyeh, Iran

[2] Urmia Univ Med Sci, Cellular & Mol Med Inst, Cellular & Mol Res Ctr, Orumiyeh, Iran

[3] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33146 USA

[4] Urmia Univ Med Sci, Expt & Appl Pharmaceut Sci Res Ctr, Orumiyeh, Iran

[5] Urmia Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Orumiyeh, Iran

[6] Urmia Univ Med Sci, Sch Fac Pharm, Dept Pharmacol & Toxicol, Sero Rd, Orumiyeh, Iran

来源：

EXPERIMENTAL AND MOLECULAR PATHOLOGY | 2022年 / 127卷

关键词：

Angiogenesis; Apoptosis; Cancer; PI3K; AKT; CELL LUNG-CANCER; INHIBITS TUMOR ANGIOGENESIS; GROWTH-FACTOR RECEPTOR; I KAPPA B; BREAST-CANCER; GASTRIC-CANCER; OVARIAN-CANCER; PANCREATIC-CANCER; UP-REGULATION; COLON-CANCER;

D O I：

10.1016/j.yexmp.2022.104787

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

The human body consists of countless cells with the possibility of excessive and uncontrolled proliferation under certain dysregulated circumstances that could cause abnormal states such as cancer. Phosphatidylinositol 3 kinase (PI3K) and its downstream target, Protein kinase B or AKT, play a critical role in cell survival, proliferation, differentiation, migration, and metabolism. Research studies have examined the aberrant expression of signaling molecules that regulate PI3K/AKT pathway with the purpose of target discovery. The present review aims to recapitulate the relationship between the PI3K/AKT signaling pathway and factors contributing to initiation and development of various cancers. In addition, therapeutic interventions regulating this signaling pathway have been summarized.

引用

页数：12

共 50 条

[1] PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression
Guo, Ningning
Wang, Xin
Xu, Muran
Bai, Jie
Yu, Hao
Zhang, Le
PHARMACOLOGICAL RESEARCH, 2024, 206
[2] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
Li, HaiXia
Zeng, JianFang
Shen, Keng
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (06) : 1067 - 1078
[3] PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer
HaiXia Li
JianFang Zeng
Keng Shen
Archives of Gynecology and Obstetrics, 2014, 290 : 1067 - 1078
[4] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
Huemer F.
Bartsch R.
Gnant M.
Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
[5] PI3K/AKT signaling and neuroprotection in ischemic stroke: molecular mechanisms and therapeutic perspectives
Liu, Tianlong
Li, Xiaolin
Zhou, Xiaowei
Chen, Wei
Wen, Aidong
Liu, Minna
Ding, Yi
NEURAL REGENERATION RESEARCH, 2025, 20 (10) : 2758 - 2775
[6] PI3K/AKT signaling and neuroprotection in ischemic stroke:molecular mechanisms and therapeutic perspectives
Tianlong Liu
Xiaolin Li
Xiaowei Zhou
Wei Chen
Aidong Wen
Minna Liu
Yi Ding
Neural Regeneration Research, 2025, 20 (10) : 2758 - 2775
[7] Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer
Su, Hua
Peng, Chao
Liu, Yang
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
[8] Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting
Qiang, Min
Chen, Zhe
Liu, Hongyang
Dong, Junxue
Gong, Kejian
Zhang, Xinjun
Huo, Peng
Zhu, Jingjun
Shao, Yifeng
Ma, Jinazun
Zhang, Bowei
Liu, Wei
Tang, Mingbo
FRONTIERS IN PHARMACOLOGY, 2025, 16
[9] PI3K/AKT signaling pathway and cancer: an updated review
Martini, Miriam
De Santis, Maria Chiara
Braccini, Laura
Gulluni, Federico
Hirsch, Emilio
ANNALS OF MEDICINE, 2014, 46 (06) : 372 - 383
[10] Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
Pavlidou, Athanasia
Vlahos, Nikos F.
SCIENTIFIC WORLD JOURNAL, 2014,

← 1 2 3 4 5 →